{
  "url": "https://www.law.cornell.edu/regulations/new-york/9-NYCRR-132.1",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 9 ยง 132.1 - Definitions",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 9 ยง 132.1 - Definitions\n\nState Regulations\n\nFor purposes of this Part, the following terms shall have the\nfollowing meanings: (a) Adverse event\nmeans any untoward or unfavorable medical\noccurrence associated with the use of a drug in human subjects, whether or not\nconsidered drug related, or damage, or any other serious important medical\nevents. (b) Applicant\nmeans\nan individual applying for a research license issued by the\n\nBoard pursuant to Article 3 section\n38\nof the Cannabis\n\nLaw, who shall also be the principal investigator. (c) Board\nmeans the New York\n\nState Cannabis Control Board as defined in Article 1 of the Cannabis\n\nLaw. (d) Cannabis-derived\nproduct\nmeans concentrated cannabis or cannabis-infused products for\nuse by a cannabis consumer or research participant. (e) Cannabis-related product\nmeans a product that may be synthetically produced to mimic or produce similar\neffects to cannabis. (f) Canopy\nmeans an area to be calculated in square feet and\nmeasured using clearly identifiable boundaries of all areas that will contain\nnon-immature cannabis, which shall be vegetative or flowering plants, excluding\nseedlings or small clones, including the space(s) within the boundaries. Canopy\nmay be noncontiguous, but each unique area included in the total canopy\ncalculations shall be separated by an identifiable boundary including, but not\nlimited to: interior walls, shelves, greenhouse walls, hoop house walls, garden\nbenches, hedge rows, fencing, garden beds, or garden plots. (g) Co-principal investigator or\n\nCo-PI\nmeans an individual whose role is similar to that of the\nprincipal investigator in determining the intellectual content, direction, and\nconduct of the research project or project activities. (h) Curriculum vitae or CV\nmeans a detailed document highlighting academic and professional\naccomplishments. (i) Double-blind trial\nmeans neither the participants of the\nresearch project nor the principal investigator and those administering the\nintervention or treatment know what intervention or treatment the participants\nare receiving. (j) Electronic data capture or EDC\nmeans software used to collect\nand manage research project data. (k) Good clinical practice\nmeans an ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve the participation of humans as\nsubjects; assurance that the rights, safety, and well-being of trial subjects\nare protected. (l) Human\nsubject or research participant\nmeans an individual participating in a\nresearch project whose data or biospecimens may be collected through\nintervention or interaction with the individual. (m) Informed consent\nmeans\nthe legally effective knowing permission and agreement of an individual or\ntheir legally authorized representative, so situated as to be able to exercise\nfree power of choice without undue inducement or any element of force, fraud, deceit, duress or other form of constraint or coercion, to engage in licensed\nresearch activities as a human subject. (n) Informed consent form or\nICF\nmeans a document to explain to the individual giving informed\nconsent of the procedures to be followed, and their purposes, including\nidentification of any procedures which are experimental, a description of any\nattendant discomforts and risks reasonably to be expected, a description of any\nbenefits reasonably to be expected, a disclosure of any appropriate alternative\nprocedures that might be advantageous for the individual, an offer to answer\nany inquiries by the individual concerning the procedures, and an instruction\nthat the individual is free to withdraw their consent and to discontinue\nparticipation in the research project at any time without prejudice. (o) Institutional review board or\nIRB\nmeans a human research review committee established and approved\nunder the provisions of article twenty-four-A of the public health law, or an\ninstitutional review board established and approved under the provisions of\n\nTitle 45 of the Code of Federal Regulations Part 46 or Title 42 of the US Code\nsection 289(a), for the purpose of reviewing and monitoring research. (p) Institutional animal care and use\ncommittee or IACUC\nmeans an independent committee that oversees all\nresearch with animals. The IACUC requires researchers to give reason to their\nneed for animals in research, ensure they select appropriate species for the\nresearch, and use of the fewest number of animals in the research to reach\ntheir desired outcome. (q) Investigational product\nmeans the cannabis, cannabis-derived\nproduct, or cannabis-related product being studied or used in an approved\nresearch project. (r) Key\npersonnel\nmeans staff, other than the PI, participating in a research\nproject who is delegated to perform research tasks. (s) Medical Cannabis Program\nmeans the administration of Article 3 of the Cannabis Law by the\n\nOffice. (t) Office\nmeans the Office of Cannabis Management. (u) Principal investigator or\nPI\nmeans the applicant or research licensee who shall also be the\nprimary individual who leads and oversees a research project and is responsible\nfor all activities conducted under the research license. (v) Protected health information or\nPHI\nmeans information in a medical, or other type of record, related\nto health care diagnosis or treatment that can be used to identify an\nindividual. It may be transmitted or maintained electronically or in any other\nform or medium. (w) Research\nmeans a systematic investigation, including but not\nlimited to, research development, testing, and evaluation, designed to develop\nor contribute to generalizable knowledge. (x) Research project or\nstudy\nmeans a formulated plan of action to perform research and the\nexecution of such plan. (y) Research and development or R&D\nmeans activities that lead\nto the innovation of new products, processes, or services, or improvements to\nthose that already exist in support of a business. (z) Research contract\nmeans\na written agreement between an applicant or research licensee and another\nlicensee, permittee or registrant approved by the Board, that contains the\nresponsibilities and duties of each party with respect to the research project\nor research study that the approved research licensee and the licensee, permittee or registrant intend to conduct under this Part. (aa)\n\nResearch protocol\nmeans\na written procedure for conducting a research project or study. (ab)\n\nSerious adverse event\nmeans an adverse event that results in death, requires hospitalization or\nprolongation of hospitalization, is life threatening, results in a permanent\ndisability or damage, results in congenital abnormality/birth defect, or\nrequires intervention to prevent permanent impairment. (ac)\n\nSingle-blind trial\nmeans a trial in which participants of a research project do not know what\ntreatment or intervention they are receiving, but key personnel administering\nthe treatment or intervention do. (ad)\n\nSub-investigator or\n\nSub-I\nmeans an individual delegated by the principal investigator to\nperform critical study procedures and assist with making key\ndecisions. (ae)\n\nVulnerable\nparticipant\nmeans an individual whose willingness to volunteer in a\nresearch project may be unduly influenced by the expectation, whether justified\nor not, of the benefits associated with participation, or of a retaliatory\nresponse from research staff if they refuse to participate. A vulnerable\nparticipant may include, but not be limited to, prisoners, minors, and those\nincapable of giving consent. Notes\nN.Y. Comp. Codes\nR. & Regs. Tit. 9\nยง\n132.1\n\nAdopted\n\nNew\n\nYork State Register August 9, 2023/Volume XLV, Issue 32, eff. 8/9/2023\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 28438
}